Pulsatile & Colon-specific DDS MCQs With Answer

Pulsatile & Colon-specific DDS MCQs With Answer

Introduction: This quiz set is designed for M.Pharm students studying Novel Drug Delivery Systems, focusing on pulsatile and colon-specific delivery technologies. It covers principles, design strategies, materials, mechanisms of release, evaluation methods, and clinical applications relevant to chronotherapeutics and colonic targeting. Questions emphasize deeper understanding—such as the role of gastrointestinal physiology, microbial enzymes, polymer science, and advanced device concepts—helping students prepare for exams and practical design challenges. Use these MCQs to test recall, apply concepts to formulation problems, and strengthen decision-making for selecting appropriate pulsatile or colon-targeting approaches for various APIs and diseases.

Q1. Which of the following best defines a pulsatile drug delivery system?

• A system that releases drug at a constant zero-order rate
• A system designed to release drug immediately and continuously
• A system that releases drug in one or more rapid bursts after a predetermined lag time
• A system that targets drug to the lymphatic system for sustained uptake

Correct Answer: A system that releases drug in one or more rapid bursts after a predetermined lag time

Q2. Which physiological rationale most commonly motivates the use of pulsatile delivery?

• To increase drug absorption in the stomach
• To match drug release with circadian rhythms of disease symptoms
• To reduce the need for prodrugs
• To avoid first-pass hepatic metabolism entirely

Correct Answer: To match drug release with circadian rhythms of disease symptoms

Q3. Which polymer is commonly used as a pH-dependent coating that dissolves at colonic pH for colon-targeting?

• Polyethylene glycol (PEG)
• Eudragit S (methacrylic acid copolymer)
• Polyvinyl alcohol (PVA)
• Hydroxypropyl methylcellulose (HPMC)

Correct Answer: Eudragit S (methacrylic acid copolymer)

Q4. Which mechanism relies primarily on bacterial azoreductases in the colon to trigger drug release?

• pH-dependent coating erosion
• Time-controlled erosion
• Prodrug linkage via azo bond
• Pressure-controlled rupture

Correct Answer: Prodrug linkage via azo bond

Q5. Which statement about multi-unit (multiparticulate) systems for colonic delivery is TRUE?

• They have higher risk of dose dumping compared to single-unit systems
• They provide more uniform gastrointestinal distribution and reduced local irritation
• They cannot be coated for pH-dependent release
• They always require enteric capsules to function

Correct Answer: They provide more uniform gastrointestinal distribution and reduced local irritation

Q6. Pulsincap is an example of which class of pulsatile drug delivery systems?

• Time-dependent hydrophilic matrix system
• Enteric-coated prodrug system
• Capsule-based lag-time device with soluble plug
• Osmotic pump delivering continuous release

Correct Answer: Capsule-based lag-time device with soluble plug

Q7. Which factor least influences colonic drug delivery success?

• Colonic microflora composition and enzyme activity
• Gastric emptying time variability
• Drug molecular weight and polarity
• Luminal pH variations along the colon

Correct Answer: Drug molecular weight and polarity

Q8. For chronotherapy of nocturnal asthma, an ideal pulsatile formulation should be designed to provide a lag time of approximately:

• 30 minutes
• 2–6 hours
• 24 hours
• 7–12 days

Correct Answer: 2–6 hours

Q9. Which in vitro evaluation technique is commonly used to simulate colonic microbial degradation of polysaccharide coatings?

• Simulated gastric fluid dissolution without enzymes
• Addition of faecal slurries or specific bacterial enzymes to dissolution medium
• High-shear mixing in distilled water
• Accelerated stability at 60°C

Correct Answer: Addition of faecal slurries or specific bacterial enzymes to dissolution medium

Q10. Which polymer is frequently used as a substrate for colon-specific enzyme degradation due to susceptibility to colonic microflora?

• Polyethylene terephthalate (PET)
• Pectin
• Polystyrene
• Polyacrylonitrile

Correct Answer: Pectin

Q11. Which colon-targeting approach is most appropriate when the drug is unstable in stomach acid but required systemically from colonic absorption?

• Use of immediate-release tablets administered with food
• Enteric/pH-dependent coating to bypass stomach and small intestine
• Enhance gastric residence with mucoadhesive polymers
• Convert drug into volatile form for inhalation

Correct Answer: Enteric/pH-dependent coating to bypass stomach and small intestine

Q12. Which statement correctly contrasts time-controlled and pH-dependent colon-targeting systems?

• Time-controlled systems always rely on bacterial enzymes, pH systems do not
• Time-controlled systems release after a predetermined lag time regardless of pH, while pH-dependent systems rely on local pH changes to dissolve coatings
• pH-dependent systems are unaffected by individual GI transit variability, while time-controlled systems are highly robust to it
• Time-controlled systems are only for peptides, pH systems only for small molecules

Correct Answer: Time-controlled systems release after a predetermined lag time regardless of pH, while pH-dependent systems rely on local pH changes to dissolve coatings

Q13. Which clinical condition is a primary therapeutic target for colon-specific delivery of 5-aminosalicylic acid (5-ASA)?

• Asthma
• Rheumatoid arthritis
• Ulcerative colitis
• Hypertension

Correct Answer: Ulcerative colitis

Q14. The main advantage of enzyme-triggered colon-specific prodrugs is:

• They eliminate need for coating technologies entirely
• They provide systemic delivery via gastric absorption
• They permit site-specific activation by colonic bacterial enzymes reducing systemic exposure
• They increase drug volatility for pulmonary delivery

Correct Answer: They permit site-specific activation by colonic bacterial enzymes reducing systemic exposure

Q15. Which evaluation method provides in vivo confirmation of site and time of drug release in the GIT?

• USP dissolution testing in simulated intestinal fluid only
• Gamma scintigraphy or imaging with radiolabelled dosage forms
• Infrared spectroscopy of powdered formulation
• Moisture sorption analysis

Correct Answer: Gamma scintigraphy or imaging with radiolabelled dosage forms

Q16. Which characteristic best describes pressure-controlled colon delivery systems?

• They rely on osmotic gradients to push drug out slowly
• They release drug when increased luminal pressure in the colon mechanically ruptures a membrane or coating
• They use light-activated polymers to trigger release
• They depend solely on pH >8 to dissolve coatings

Correct Answer: They release drug when increased luminal pressure in the colon mechanically ruptures a membrane or coating

Q17. Which colonic microbial genera are among the most important for biodegradation of polysaccharide coatings?

• Staphylococcus and Streptococcus
• Bacteroides and Clostridium
• Mycobacterium and Nocardia
• Escherichia coli only

Correct Answer: Bacteroides and Clostridium

Q18. For a drug requiring pulsatile release in the early morning for rheumatoid arthritis symptoms, which formulation strategy is most suitable for oral administration at bedtime?

• Immediate-release tablet taken at bedtime
• Time-dependent core tablet with an erodible outer coat providing a 6–8 hour lag time
• Continuous infusion via implantable pump
• Formulation that releases drug only in the stomach over 12 hours

Correct Answer: Time-dependent core tablet with an erodible outer coat providing a 6–8 hour lag time

Q19. Which limitation is commonly associated with pH-dependent colon-targeting systems?

• They are completely independent of intersubject variability
• Variability in individual GI pH and diseases like IBD can cause premature or delayed release
• They require high energy radiation for activation
• They cannot be combined with multiparticulate systems

Correct Answer: Variability in individual GI pH and diseases like IBD can cause premature or delayed release

Q20. Which design consideration is most critical when formulating colon-specific delivery of peptides and proteins?

• Ensuring rapid gastric absorption to avoid colonic release
• Protecting the biomolecule from proteolytic degradation in upper GIT and enabling release in colon where local protease activity differs
• Aiming for immediate release in the stomach to utilize low pH stability
• Formulating for inhalation because peptides cannot be delivered orally

Correct Answer: Protecting the biomolecule from proteolytic degradation in upper GIT and enabling release in colon where local protease activity differs

Download